Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103304478A details a high-yield Pictet-Spengler route for bis-tetrahydroisoquinoline alkaloids, offering cost-effective API intermediate manufacturing solutions.
Patent CN112574056B reveals a green photocatalytic route for alpha,alpha-difluoro-gamma-hydroxyacetamide derivatives, offering cost reduction and scalable manufacturing for pharma.
Novel patent CN106749116B details efficient synthesis of 3-aminomethyl tetrahydrofuran offering high purity and scalable production for global pharmaceutical intermediate supply chains.
Patent CN1070833C details a high-yield route for cyclopropylacetylene derivatives, offering cost-effective manufacturing and scalable supply chain solutions for API intermediates.
Novel patent CN101665407B enables high-purity 2,4,5-trifluorobenzyl chloride production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN112088003A details a regioselective route for LRRK2 inhibitors. Offers scalable synthesis, improved purity, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105254603A reveals optimized SMIA synthesis. Reduces trans-isomers, improves purity. Ideal for cephalosporin production supply chains.
Patent CN106854200B reveals high-purity Ceritinib synthesis. Optimized catalytic route ensures supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Patent CN112851560A reveals a cost-effective racemization method for cis-D-hydroxyproline, offering high purity >99.5% and scalable production for pharma intermediates.
Patent CN108929335B details a resin-based purification method for Tacrolimus, offering high purity, reduced solvent use, and scalable manufacturing for global supply chains.
Patent CN115305490B reveals electro-oxidative synthesis for fluoroalkyl dibenzosuberones. Offers green chemistry advantages for pharmaceutical intermediate supply chains and cost reduction.
Novel green route for Sonidegib intermediates via epoxide ring-opening. Eliminates expensive chiral starting materials and reduces wastewater for cost-effective manufacturing.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113512569B details a green enzymatic route for Lopinavir intermediates. Achieve high purity and cost reduction in API manufacturing with our advanced biocatalytic solutions.
Novel electrochemical method for tazobactam key intermediate improves yield and reduces steps compared to traditional halogenation routes.
Patent CN115820782A reveals a green enzymatic route for 7-dehydrocholesterol intermediates, offering superior purity and yield for Vitamin D3 synthesis.
Advanced catalytic elimination and epoxidation method for 4β,5β-epoxy-Δ6-steren-3β-alcohol. High stereoselectivity, cost-effective route for steroidal API manufacturing.
Patent CN111138361B reveals novel antitumor intermediates with improved safety profiles. Discover scalable synthesis routes and cost-effective manufacturing strategies for pharmaceutical applications.
Novel synthesis method for TAK-875 intermediate ensuring high purity and scalable production for global pharmaceutical supply chains.